Bio-Rad Laboratories Net Income 2010-2023 | BIO
Bio-Rad Laboratories annual/quarterly net income history and growth rate from 2010 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Bio-Rad Laboratories net income for the quarter ending December 31, 2023 was $0.350B, a 57.75% decline year-over-year.
- Bio-Rad Laboratories net income for the twelve months ending December 31, 2023 was $-0.637B, a 82.43% decline year-over-year.
- Bio-Rad Laboratories annual net income for 2023 was $-0.637B, a 82.43% decline from 2022.
- Bio-Rad Laboratories annual net income for 2022 was $-3.628B, a 185.27% decline from 2021.
- Bio-Rad Laboratories annual net income for 2021 was $4.254B, a 11.54% increase from 2020.
| Bio-Rad Laboratories Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $-637 |
| 2022 | $-3,628 |
| 2021 | $4,254 |
| 2020 | $3,814 |
| 2019 | $1,759 |
| 2018 | $366 |
| 2017 | $122 |
| 2016 | $26 |
| 2015 | $109 |
| 2014 | $89 |
| 2013 | $78 |
| 2012 | $165 |
| 2011 | $179 |
| 2010 | $185 |
| 2009 | $145 |
| Bio-Rad Laboratories Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2023-12-31 | $350 |
| 2023-09-30 | $106 |
| 2023-06-30 | $-1,162 |
| 2023-03-31 | $69 |
| 2022-12-31 | $828 |
| 2022-09-30 | $-163 |
| 2022-06-30 | $-925 |
| 2022-03-31 | $-3,367 |
| 2021-12-31 | $-1,565 |
| 2021-09-30 | $3,928 |
| 2021-06-30 | $914 |
| 2021-03-31 | $977 |
| 2020-12-31 | $847 |
| 2020-09-30 | $1,315 |
| 2020-06-30 | $966 |
| 2020-03-31 | $686 |
| 2019-12-31 | $553 |
| 2019-09-30 | $-259 |
| 2019-06-30 | $599 |
| 2019-03-31 | $865 |
| 2018-12-31 | $-829 |
| 2018-09-30 | $269 |
| 2018-06-30 | $268 |
| 2018-03-31 | $657 |
| 2017-12-31 | $83 |
| 2017-09-30 | $22 |
| 2017-06-30 | $5 |
| 2017-03-31 | $12 |
| 2016-12-31 | $-23 |
| 2016-09-30 | $18 |
| 2016-06-30 | $18 |
| 2016-03-31 | $12 |
| 2015-12-31 | $46 |
| 2015-09-30 | $17 |
| 2015-06-30 | $28 |
| 2015-03-31 | $18 |
| 2014-12-31 | $39 |
| 2014-09-30 | $12 |
| 2014-06-30 | $32 |
| 2014-03-31 | $7 |
| 2013-12-31 | $30 |
| 2013-09-30 | $-7 |
| 2013-06-30 | $35 |
| 2013-03-31 | $20 |
| 2012-12-31 | $43 |
| 2012-09-30 | $43 |
| 2012-06-30 | $48 |
| 2012-03-31 | $31 |
| 2011-12-31 | $60 |
| 2011-09-30 | $46 |
| 2011-06-30 | $40 |
| 2011-03-31 | $33 |
| 2010-12-31 | $68 |
| 2010-09-30 | $45 |
| 2010-06-30 | $38 |
| 2010-03-31 | $35 |
| 2009-12-31 | $38 |
| 2009-09-30 | $39 |
| 2009-06-30 | $38 |
| 2009-03-31 | $30 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $7.989B | $2.671B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $185.786B | 24.39 |
| Stryker (SYK) | United States | $124.672B | 30.91 |
| Medtronic (MDT) | Ireland | $106.983B | 15.15 |
| Boston Scientific (BSX) | United States | $99.792B | 33.18 |
| EssilorLuxottica (ESLOY) | France | $98.590B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.472B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.173B | 29.86 |
| ResMed (RMD) | United States | $26.527B | 26.52 |
| Terumo (TRUMY) | Japan | $25.252B | 35.66 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.816B | 15.98 |
| Baxter (BAX) | United States | $20.516B | 14.96 |
| Koninklijke Philips (PHG) | Netherlands | $19.139B | 15.27 |
| Insulet (PODD) | United States | $11.513B | 60.45 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.649B | 0.00 |
| Demant (WILYY) | Denmark | $9.853B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.214B | 38.79 |
| Lantheus Holdings (LNTH) | United States | $4.324B | 11.16 |
| Haemonetics (HAE) | United States | $4.247B | 21.72 |
| Perrigo (PRGO) | Ireland | $4.074B | 11.65 |
| GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
| Prestige Consumer Healthcare (PBH) | United States | $3.466B | 16.39 |
| Envista Holdings (NVST) | United States | $3.456B | 13.14 |
| QuidelOrtho (QDEL) | United States | $2.614B | 9.49 |
| Neogen (NEOG) | United States | $2.552B | 24.54 |
| Green Thumb Industries (GTBIF) | United States | $2.526B | 80.07 |
| ICU Medical (ICUI) | United States | $2.348B | 17.52 |
| TG Therapeutics (TGTX) | United States | $2.179B | 705.00 |
| Owens & Minor (OMI) | United States | $1.856B | 17.82 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.853B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.698B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.652B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.444B | 44.98 |
| InMode (INMD) | Israel | $1.439B | 7.45 |
| LeMaitre Vascular (LMAT) | United States | $1.409B | 46.50 |
| AdaptHealth (AHCO) | United States | $1.276B | 9.60 |
| Warby Parker (WRBY) | United States | $1.218B | 0.00 |
| AtriCure (ATRC) | United States | $1.099B | 0.00 |
| MacroGenics (MGNX) | United States | $0.964B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.761B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.715B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.693B | 14.97 |
| Cresco Labs (CRLBF) | United States | $0.684B | 0.00 |
| Evolus (EOLS) | United States | $0.679B | 0.00 |
| Quanterix (QTRX) | United States | $0.623B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| Jin Medical (ZJYL) | China | $0.532B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.529B | 11.45 |
| PetIQ (PETQ) | United States | $0.486B | 18.14 |
| TerrAscend (TSNDF) | Canada | $0.475B | 0.00 |
| ZimVie (ZIMV) | United States | $0.422B | 25.82 |
| Biote (BTMD) | United States | $0.414B | 3.94 |
| OraSure Technologies (OSUR) | United States | $0.409B | 6.77 |
| Surmodics (SRDX) | United States | $0.361B | 39.06 |
| Zynex (ZYXI) | United States | $0.358B | 41.26 |
| Aurora Cannabis (ACB) | Canada | $0.343B | 0.00 |
| Cerus (CERS) | United States | $0.306B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.304B | 30.15 |
| Sanara MedTech (SMTI) | United States | $0.284B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.263B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.245B | 14.91 |
| Organigram Holdings (OGI) | Canada | $0.196B | 0.00 |
| Veru (VERU) | United States | $0.186B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.183B | 0.00 |
| Omeros (OMER) | United States | $0.178B | 0.00 |
| High Tide (HITI) | Canada | $0.171B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.160B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.156B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.133B | 66.92 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.77 |
| Jushi Holdings (JUSHF) | United States | $0.127B | 0.00 |
| InterCure (INCR) | Israel | $0.115B | 19.46 |
| Cellectar Biosciences (CLRB) | United States | $0.103B | 0.00 |
| Fonar (FONR) | United States | $0.103B | 8.80 |
| MariMed (MRMD) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.091B | 0.00 |
| Chimerix (CMRX) | United States | $0.082B | 0.00 |
| Brainsway (BWAY) | Israel | $0.079B | 0.00 |
| Safety Shot (SHOT) | United States | $0.077B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.065B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Apyx Medical (APYX) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Bright Green (BGXX) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.52 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.73 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.001B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |